The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

+ Details

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Payments to be made in warrants upon reaching prescribed annual net sales under the development and license agreement.

+ References

No definition available.

+ Details

Name:	zom_DevelopmentAndLicenseAgreementContingentOnAnnualNetSalesPayableInWarrants
Namespace Prefix:	zom_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Payments to be made in warrants on the first commercial sale of the product under the development and license agreement.

+ References

No definition available.

+ Details

Name:	zom_DevelopmentAndLicenseAgreementContingentOnFirstCommercialSaleOfProductPayableInWarrants
Namespace Prefix:	zom_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the term which is used in calculating milestone payments payable in warrants.

+ References

No definition available.

+ Details

Name:	zom_DevelopmentAndLicenseAgreementContingentOnFirstCommercialSaleOfProductPayableInWarrantsTerm
Namespace Prefix:	zom_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Target annual net sales to be reached for the milestone payments to be paid in cash.

+ References

No definition available.

+ Details

Name:	zom_DevelopmentAndLicenseAgreementTargetAnnualNetSales
Namespace Prefix:	zom_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- References

No definition available.

+ Details

Name:	zom_DevelopmentCommercializationAndExclusiveDistributionAgreementContingentOnAchievementOfDevelopmentMilestoneCash
Namespace Prefix:	zom_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- References

No definition available.

+ Details

Name:	zom_DevelopmentCommercializationAndExclusiveDistributionAgreementContingentOnAchievementOfDevelopmentMilestoneEquity
Namespace Prefix:	zom_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of cash milestone payments due.

+ References

No definition available.

+ Details

Name:	zom_MilestoneCashPaymentsDue
Namespace Prefix:	zom_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Cash outflow for milestone payments.

+ References

No definition available.

+ Details

Name:	zom_PaymentsForMilestonesAchieved
Namespace Prefix:	zom_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=zom_BrisbyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=zom_SeraphBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=zom_BrisbyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=zom_SmartPetPadMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=zom_IntelligentPetPadMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Agreements (Details) - USD ($) $ in Thousands	Apr. 04, 2023	Sep. 30, 2024	May 10, 2018
Brisby Inc
Commitments and Contingencies
Equity method investment (as a percent)		19.50%
Seraph Biosciences
Commitments and Contingencies
Milestone payable in cash or combination			$ 3,500
Milestone payable in equity			$ 3,500
Brisby Inc
Commitments and Contingencies
Milestone payable in cash or combination	$ 3,500
Milestone on annual net sales in warrants	5,000
Milestone target annual net sales	15,000
Payments for milestones achieved		$ 1,563
Remaining cash payments due		$ 1,937
Brisby Inc \| Smart Pet Pad
Commitments and Contingencies
Milestone on first commercial sale of product in warrants	$ 750
Milestone consideration term	10 years
Brisby Inc \| Intelligent Pet Pad
Commitments and Contingencies
Milestone on first commercial sale of product in warrants	$ 750
Milestone consideration term	10 years